@drtimos.bsky.social🚀 Contributed to FirstWord report on AI in personalized medicine: smarter trials, faster discovery 🧬💊. Early AI drugs show 80–90% Ph 1 success! 🌍 Challenges remain, but partnerships & continuous learning will drive the future. #LucidQuest
Read more 👉 http://dlvr.it/TVX4bL
@drtimos.bsky.socialLucidQuest YouTube > Rare Diseases Strategic Roundup | Aug 12 - Sep 16, 2026: From 12 August – 16 September 2026, rare-disease competition increasingly shifted from scientific validation toward execution after approval. This Strategic Roundup explores the… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.socialLucidQuest YouTube > Rare Diseases Strategic Roundup: From Access To Approval | Aug 12 - Sep 16, 2026: In this Rare Diseases Strategic Roundup, covering 12 August–16 September 2026, we examine how competition is moving beyond clinical validation toward a… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🚨 Who’s leading BioPharma (+ Google) CVC in 2025?
🔎 #LucidQuest analyzed 22 CVCs—focus by Tech & Therapy Areas + shifts vs. 2023.
Grab the FREE snapshot ⚡
@drtimos.bsky.socialYour launch may look great on Google, but AI answers can cite others. #LucidScope tracks perception + answer differences across models and personas, with source tracing and risk flags. Start with an AI Answer Audit: http://dlvr.it/TVV8s1 #LucidQuest
@drtimos.bsky.socialZero-click is here: AI summaries decide what gets seen. #LucidScope benchmarks how major models describe you vs competitors, spots outdated or hallucinated claims, and recommends content + schema actions. Request an audit: http://dlvr.it/TVTt0Q #LucidQuest
@drtimos.bsky.social🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TVTFn5 #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
@drtimos.bsky.social🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVSzLc #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@drtimos.bsky.socialLucidQuest YouTube > Oncology Strategic Roundup: Earlier-Line Expansion | Aug 07 - Sep 10, 2026: The latest edition of the Oncology Strategic Roundup, covering developments from August 7 to September 10, 2026, highlights a market moving earlier in treatment… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.socialWhat if strategy felt like live chess?
#LucidWargames runs dynamic sims, pits you vs adaptive AI rivals, adjudicates by KPIs, and maps odds with 100+ Monte Carlo runs.
Prep or power your next session with rigor: http://dlvr.it/TVSbKF
Demo: http://dlvr.it/TVSbKG
#LucidQuest
@drtimos.bsky.socialFrom slides to simulations. #LucidWargames, a multi-agent engine, pressure tests strategy with evolving scenarios, objective scoring, and probability maps from 100+ Monte Carlo runs. Optimize your next workshop: http://dlvr.it/TVSVDM Demo: http://dlvr.it/TVSVDP #LucidQuest
@drtimos.bsky.social🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TVSKnB !
@drtimos.bsky.socialStay ahead in healthcare innovation.
Subscribe to #LucidQuest's Weekly LQ AI Report for #AI breakthroughs, #PrecisionMedicine insights & #DigitalHealth trends.
Get tips & success stories delivered to your inbox. http://dlvr.it/TVSHpX
@drtimos.bsky.social🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TVRwF2
@ASCO
#SocialListening #LucidQuest
@drtimos.bsky.social#LucidQuest helps Pharma/Biotech/HealthTech teams turn market signals into decisions, fast.
Start with #QuickAnswers (rapid primary + secondary CI), scale to deeper projects, conference coverage, #LucidWargames simulations, #LucidScope AI narrative audits, and #NexusBrain insight capture.
@drtimos.bsky.socialLucidQuest YouTube > Vaccines Strategic Roundup | Aug 08 – Sept 10, 2026: From 08 August – 10 September 2026, vaccine market developments highlighted the growing strategic importance of platform adaptability across infectious disease, seasonal vaccination,… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TVRM3f | 📧 Talk to experts: [email protected]
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest
@drtimos.bsky.socialLucidQuest YouTube > Vaccines Strategic Roundup | Aug 08 – Sept 10, 2026: The latest Vaccines Strategic Roundup, covering developments from 8 August–10 September 2026, highlights how vaccine platform adaptability is becoming a more important source of… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🚀 Conference coverage to #CGT strategy. #LucidQuest turns congress signals into structured intel: what changed, who it affects, next steps for teams and investors. Previews, recaps, KOLs, CI tracking, decision-ready outputs. 📩 [email protected]
@drtimos.bsky.socialHow to win in #Oncology and #Hematology in 2025
📥 Get a FREE #LucidQuest Report http://dlvr.it/TVQsSS
🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.
🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.